Cipla Medpro won 173 million US dollars order to supply Anti-Retroviral Drugs to South Africa
Cipla Medpro won 173 million US dollars order to supply Anti-Retroviral Drugs to government of South Africa for its anti-AIDS programme.
Cipla Medpro won 173 million US dollars (2 billion-rand) order to supply Anti-Retroviral Drugs (ARD) to government of South Africa for its anti-AIDS programme for the next three years.
The antiretroviral drugs will be produced in Kwazulu-Natal province Plant which will start on 1 April 2015. This is the third order that the Cipla Medpro has won from government of South Africa in 2014.
Earlier, Cipla Medpro had won from the government of South Africa 280 million rupees of state therapeutic drug tender in August 2014 and 345 million rupees of national respiratory tender in June 2014.
South Africa has the biggest antiretroviral treatment program of the world. It offers medication to more than 2.2 million people of South Africa. The government of South Africa has a target of halving the number of new HIV infections by 2016.
About Cipla Medpro
Cipla is the world's largest manufacturer of antiretroviral drugs to fight HIV/AIDS. Cipla Medpro has been a unit of Mumbai-based Cipla Ltd which acquired Cipla Medpro for about 4.5 billion US dollars in 2013.
Cipla Medpro chief executive officer: Paul Miller